Octapharma Research Site
Durham, North Carolina 27710
We've found
2 trials
at this facility
Adverse Effects in the Therapeutic Use of Plasma Substitutes Clinical Trial
Updated: 12/31/1969
Octaplas Pediatric Plasma Exchange Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Significant Bleeding Risk Clinical Trial
Updated: 12/31/1969
Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials